Cargando…
Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms
BACKGROUND: Despite timely administration of IVIG, some patients with Kawasaki disease (KD) develop rapidly progressive or giant coronary artery aneurysms (CAA). CASE PRESENTATION: We describe our experience using cyclophosphamide (CYC) for the treatment of such cases as well as a review of the lite...
Autores principales: | Halyabar, Olha, Friedman, Kevin G., Sundel, Robert P., Baker, Annette L., Chang, Margaret H., Gould, Patrick W., Newburger, Jane W., Son, Mary Beth F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968156/ https://www.ncbi.nlm.nih.gov/pubmed/33731148 http://dx.doi.org/10.1186/s12969-021-00526-0 |
Ejemplares similares
-
Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population
por: Son, Mary Beth F., et al.
Publicado: (2019) -
Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline z Scores
por: Son, Mary Beth F., et al.
Publicado: (2017) -
Coronary artery aneurysms in children is not always Kawasaki disease: a case report on Takayasu arteritis
por: Lee, Michelle, et al.
Publicado: (2021) -
Kawasaki Disease
por: Son, Mary Beth, et al.
Publicado: (2016) -
Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population
por: Friedman, Kevin G., et al.
Publicado: (2016)